Wishing you all the joys of the season! 
Europe Neurostimulation Devices Market Forecast to 2030
Europe Neurostimulation Devices Market Forecast to 2030 – Regional Analysis – by Product (Spinal Cord Stimulator, Deep Brain Stimulator, Sacral Nerve Stimulator, Vagus Nerve Stimulator, and Others), Application (Pain Management, Epilepsy, Urinary and Fecal Incontinence, Parkinson’s Disease, and Others), and End User (Hospitals, Specialty Clinics, and Others)
$2,485 – $3,885
- Description
- Toplines
- Reasons for Buying
- Table of Contents
- List of Tables
- LIst of Figures
- List of Companies
- Reviews (0)
Description
Rising Cases of Spinal Cord Injury Fuel Europe Neurostimulation Devices Market
The neurostimulation devices industry has gained traction owing to the rising elderly population prone to various spinal disorders. These population is becoming more susceptible to developing spinal disorders such as degenerative disc diseases, osteoarthritis, scoliosis, spinal tumor, and spinal stenosis. As this population ages, the natural wear and tear of the spine can lead to several spinal disorders. Hence, with this fact, the aging population poses a unique challenge to spine surgeons due to multiple increased frailty, medical comorbidities, decreased nutritional status, and the higher probability of postoperative complications. According to the World Health Organization (WHO) data published in October 2022, approximately 80% of the elderly population will be living in low-and middle-income countries by 2050, and it is anticipated that the pace of this population aging will be much faster than in the past. The aging demographic, coupled with lifestyle-related factors has led to a substantial increase in individuals experiencing spinal issues such as degenerative disc disease and spinal deformities. Therefore, high incidence of spinal cord injuries in old age and adults stimulates the demand for neurostimulation devices.
Europe Neurostimulation Devices Market Overview
The Europe neurostimulation devices market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. The regional market is expected to grow significantly in the coming years owing to the rising prevalence of neurologic disorders such as cerebral aneurysms, stroke, and others and increasing product innovations made by the market players operating in the region. The market growth is also attributed to the development of healthcare systems in countries such as Germany, France, and Spain and rise in innovative product launches by key regional companies. In June 2020, Medtronic announced the launch of the PerceptTM PC Neurostimulator with BrainsenseTM technology. The technology simultaneously records and delivers electrical stimulations to the brain to relieve symptoms of Parkinson’s disease (PD).
Europe Neurostimulation Devices Market Revenue and Forecast to 2030 (US$ Million)
Europe Neurostimulation Devices Market Segmentation
The Europe neurostimulation devices market is segmented based on product, application, end user, and country.
Based on product, the Europe neurostimulation devices market is segmented into spinal cord stimulator, deep brain stimulator, sacral nerve stimulator, vagus nerve stimulator, and others. The spinal cord stimulator segment held the largest market share in 2022.
In terms of application, the Europe neurostimulation devices market is categorized into pain management, epilepsy, urinary and fecal incontinence, Parkinson’s disease, and others. The pain management segment held the largest market share in 2022.
By end user, the Europe neurostimulation devices market is segmented into hospitals, specialty clinics, and others. The hospitals segment held the largest market share in 2022.
Based on country, the Europe neurostimulation devices market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe neurostimulation devices market share in 2022.
Medtronic Plc, Boston Scientific Corp, Abbott Laboratories, Nevro Corp, LivaNova Plc, Synapse Biomedical Inc, ElectroCore Inc, and Mainstay Medical are some of the leading companies operating in the Europe neurostimulation devices market.
Summary Info
| Industry: | |
|---|---|
| Pricing options: | |
| Geographical coverage: | |
| Year of Publication: |
According to the Research Team’ research, the Europe neurostimulation devices market was valued at US$ 1,717.84 million in 2022 and is expected to reach US$ 3,459.24 million by 2030, registering a CAGR of 9.1% from 2022 to 2030. Growing advances and approvals for neurostimulation devices and rising cases of spinal cord injury are among the critical factors attributed to the Europe neurostimulation devices market expansion.
Manufacturers are investing a significant amount in developing advanced products and technologies such as implantable neurostimulation devices. Additionally, an increase in Food and Drug Administration (FDA) approvals for novel neurostimulators with new applications are observed in the neurostimulation devices market. Following are a few advances and approvals for the neurostimulation devices. In February 2021, Mainstay Medical developed an implantable restorative neurostimulation system, ReActiv8, to treat intractable chronic low back pain. In March 2021, Abbott launched NeuroSphere, a virtual clinic designed to help deep brain stimulation patients program and reset their devices remotely from the comfort of their own homes. In January 2021, Boston Scientific Corporation released the WaveWriter Alpha, a portfolio of Spinal Cord Stimulator (SCS) systems that combine therapy options for personalized pain relief. Therefore, the rising number of advances and approvals for neurostimulation devices is expected to provide lucrative opportunities for the neurostimulation devices market during the forecast period.
On the contrary, lack of expert professionals hampers the growth of Europe neurostimulation devices market.
Based on product, the Europe neurostimulation devices market is segmented into spinal cord stimulator, deep brain stimulator, sacral nerve stimulator, vagus nerve stimulator, and others. The spinal cord stimulator segment held 50.6% market share in 2022, amassing US$ 869.56 million. It is projected to garner US$ 1,816.09 million by 2030 to expand at 9.6% CAGR during 2022-2030.
In terms of application, the Europe neurostimulation devices market is categorized into pain management, epilepsy, urinary and fecal incontinence, Parkinson’s disease, and others. The pain management segment held 52.2% share of Europe neurostimulation devices market in 2022, amassing US$ 896.49 million. It is projected to garner US$ 1,878.46 million by 2030 to expand at 9.7% CAGR during 2022-2030.
By end user, the Europe neurostimulation devices market is segmented into hospitals, specialty clinics, and others. The hospitals segment held 58.7% share of Europe neurostimulation devices market in 2022, amassing US$ 1,008.21 million. It is projected to garner US$ 2,059.01 million by 2030 to expand at 9.3% CAGR during 2022-2030.
Based on country, the Europe neurostimulation devices market has been categorized into the UK, Germany, France, Italy, Spain, and the Rest of Europe. Our regional analysis states that Germany captured 26.6% share of Europe neurostimulation devices market in 2022. It was assessed at US$ 456.14 million in 2022 and is likely to hit US$ 936.97 million by 2030, exhibiting a CAGR of 9.4% during 2022-2030.
Key players operating in the Europe neurostimulation devices market are Medtronic Plc, Boston Scientific Corp, Abbott Laboratories, Nevro Corp, LivaNova Plc, Synapse Biomedical Inc, ElectroCore Inc, and Mainstay Medical, among others.
In September 2020, Boston Scientific launched Wavewriter Alpha Spinal Cord Stimulator Systems in Europe.
In July 2021, Nevro Announced the FDA Approval of its 10 kHz High Frequency Spinal Cord Stimulation Therapy for Treatment of Chronic Pain Associated with Painful Diabetic Neuropathy (PDN).
o Highlights key business priorities in order to assist companies to realign their business strategies
o The key findings and recommendations highlight crucial progressive industry trends in the Europe neurostimulation devices market, thereby allowing players across the value chain to develop effective long-term strategies
o Develop modify business expansion plans by using substantial growth offering developed and emerging markets
o Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the Europe neurostimulation devices market, as well as those hindering it
o Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution
TABLE OF CONTENTS
1.1 the Research Team Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Neurostimulation Devices Market – Key Industry Dynamics
4.1 Market Drivers
4.1.1 Increasing Prevalence of Neurological Disorders
4.1.2 Rising Cases of Spinal Cord Injury
4.2 Market Restraints
4.2.1 Lack of Expert Professionals
4.3 Market Opportunities
4.3.1 Growing Advances and Approvals for Neurostimulation Devices
4.4 Future Trends
4.4.1 Rising Demand for Noninvasive Treatment
4.5 Impact Analysis
5. Neurostimulation Devices Market – Europe Market Analysis
5.1 Europe Neurostimulation Devices Market Revenue (US$ Mn), 2022 – 2030
6. Europe Neurostimulation Devices Market – Revenue and Forecast to 2030 – by Product
6.1 Overview
6.2 Europe Neurostimulation Devices Market Revenue Share, by Product 2022 & 2030 (%)
6.3 Spinal Cord Stimulator
6.3.1 Overview
6.3.2 Spinal Cord Stimulator: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
6.4 Deep Brain Stimulator
6.4.1 Overview
6.4.2 Deep Brain Stimulator: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
6.5 Sacral Nerve Stimulator
6.5.1 Overview
6.5.2 Sacral Nerve Stimulator: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
6.6 Vagus Nerve Stimulator
6.6.1 Overview
6.6.2 Vagus Nerve Stimulator: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
6.7 Others
6.7.1 Overview
6.7.2 Others: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
7. Europe Neurostimulation Devices Market – Revenue and Forecast to 2030 – by Application
7.1 Overview
7.2 Neurostimulation Devices Market Revenue Share, by Application 2022 & 2030 (%)
7.3 Pain Management
7.3.1 Overview
7.3.2 Pain Management: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Epilepsy
7.4.1 Overview
7.4.2 Epilepsy: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
7.5 Urinary and Fecal Incontinence
7.5.1 Overview
7.5.2 Urinary and Fecal Incontinence: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
7.6 Parkinson’s Disease
7.6.1 Overview
7.6.2 Parkinson’s Disease: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
7.7 Others
7.7.1 Overview
7.7.2 Others: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
8. Europe Neurostimulation Devices Market – Revenue and Forecast to 2030 – by End User
8.1 Overview
8.2 Europe Neurostimulation Devices Market Revenue Share, by End User 2022 & 2030 (%)
8.3 Hospitals
8.3.1 Overview
8.3.2 Hospitals: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Specialty Clinics
8.4.1 Overview
8.4.2 Specialty Clinics: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Others
8.5.1 Overview
8.5.2 Others: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
9. Europe Neurostimulation Devices Market – Revenue and Forecast to 2030 – Country Analysis
9.1 Europe: Neurostimulation Devices Market
9.1.1 Overview
9.1.2 Europe: Neurostimulation Devices Market, by Country, 2022 & 2030 (%)
9.1.2.1 Germany: Neurostimulation Devices Market – Revenue and Forecast to 2030 (USD Million)
9.1.2.2 Germany: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
9.1.2.2.1 Germany: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
9.1.2.2.2 Germany: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
9.1.2.2.3 Germany: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
9.1.2.3 UK: Neurostimulation Devices Market – Revenue and Forecast to 2030 (USD Million)
9.1.2.4 UK: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
9.1.2.4.1 UK: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
9.1.2.4.2 UK: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
9.1.2.4.3 UK: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
9.1.2.5 France: Neurostimulation Devices Market – Revenue and Forecast to 2030 (USD Million)
9.1.2.6 France: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
9.1.2.6.1 France: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
9.1.2.6.2 France: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
9.1.2.6.3 France: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
9.1.2.7 Italy: Neurostimulation Devices Market – Revenue and Forecast to 2030 (USD Million)
9.1.2.8 Italy: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
9.1.2.8.1 Italy: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
9.1.2.8.2 Italy: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
9.1.2.8.3 Italy: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
9.1.2.9 Spain: Neurostimulation Devices Market – Revenue and Forecast to 2030 (USD Million)
9.1.2.10 Spain: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
9.1.2.10.1 Spain: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
9.1.2.10.2 Spain: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
9.1.2.10.3 Spain: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
9.1.2.11 Rest of Europe: Neurostimulation Devices Market – Revenue and Forecast to 2030 (USD Million)
9.1.2.12 Rest of Europe: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
9.1.2.12.1 Rest of Europe: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
9.1.2.12.2 Rest of Europe: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
9.1.2.12.3 Rest of Europe: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
10. Neurostimulation Devices Market-Industry Landscape
10.1 Overview
10.2 Organic Developments
10.2.1 Overview
10.3 Inorganic Developments
10.3.1 Overview
11. Company Profiles
11.1 Medtronic Plc
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Boston Scientific Corp
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Abbott Laboratories
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Nevro Corp
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 LivaNova Plc
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 Synapse Biomedical Inc.
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 ElectroCore Inc
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 Mainstay Medical
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Products and Services
11.8.4 Financial Overview
11.8.5 SWOT Analysis
11.8.6 Key Developments
12. Appendix
12.1 About Us
12.2 Glossary of Terms
LIST OF TABLES
Table 1. Neurostimulation Devices Market Segmentation
Table 2. Germany Neurostimulation Devices Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 3. Germany Neurostimulation Devices Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 4. Germany Neurostimulation Devices Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 5. UK Neurostimulation Devices Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 6. UK Neurostimulation Devices Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 7. UK Neurostimulation Devices Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 8. France Neurostimulation Devices Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 9. France Neurostimulation Devices Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 10. France Neurostimulation Devices Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 11. Italy Neurostimulation Devices Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 12. Italy Neurostimulation Devices Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 13. Italy Neurostimulation Devices Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 14. Spain Neurostimulation Devices Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 15. Spain Neurostimulation Devices Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 16. Spain Neurostimulation Devices Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 17. Rest of Europe Neurostimulation Devices Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 18. Rest of Europe Neurostimulation Devices Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 19. Rest of Europe Neurostimulation Devices Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 20. Organic Developments Done by Companies
Table 21. Inorganic Developments Done by Companies
Table 22. Glossary of Terms, Neurostimulation Devices Market
LIST OF FIGURES
Figure 1. Neurostimulation Devices Market Segmentation, By Country
Figure 2. Neurostimulation Devices Market: Key Industry Dynamics
Figure 3. Neurostimulation Devices Market: Impact Analysis of Drivers and Restraints
Figure 4. Europe Neurostimulation Devices Market Revenue (US$ Mn), 2020 – 2030
Figure 5. Europe Neurostimulation Devices Market Revenue Share, by Product 2022 & 2030 (%)
Figure 6. Spinal Cord Stimulator: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 7. Deep Brain Stimulator: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8. Sacral Nerve Stimulator: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Vagus Nerve Stimulator: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 10. Others: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Neurostimulation Devices Market Revenue Share, by Application 2022 & 2030 (%)
Figure 12. Pain Management: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. Epilepsy: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. Urinary and Fecal Incontinence: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. Parkinson’s Disease: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. Others: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. Europe Neurostimulation Devices Market Revenue Share, by End User 2022 & 2030 (%)
Figure 18. Hospitals & Clinics: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. Specialty Clinics: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 20. Others: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 21. Europe: Neurostimulation Devices Market, by Key Country – Revenue (2022) (US$ Million)
Figure 22. Europe: Neurostimulation Devices Market, by Country, 2022 & 2030 (%)
Figure 23. Germany: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 24. UK: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 25. France: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 26. Italy: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 27. Spain: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 28. Rest of Europe: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
The List of Companies – Europe Neurostimulation Devices Market
1. Medtronic Plc
2. Boston Scientific Corp
3. Abbott Laboratories
4. Nevro Corp
5. LivaNova Plc
6. Synapse Biomedical Inc
7. ElectroCore Inc
8. Mainstay Medical
You must be logged in to post a review.
Reviews
There are no reviews yet.